Editors

Editors-in-Chief
Arnold J.M. Driessen, PhD, Faculty of Science and Engineering, University of Groningen, Netherlands
Yu-quan Wei, PhD, MD, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, China

Associate Editors
George A. Calin, PhD, MD, MD Anderson Cancer Center, USA
Chen Dong, PhD, Tsinghua University, China
Dongsheng Duan, PhD, University of Missouri, USA
Masanori Fukushima, PhD, MD, Translational Research Center for Medical Innovation, Japan
George Fu Gao, PhD, Chinese Academy of Sciences, China
Jia-huai Han, PhD, Xiamen University, China
Haya Lorberboum-Galski, PhD, Hebrew University, Israel
Edouard Nice, PhD, Monash University, Australia
Christophe P. Nicot, PhD, The University of Kansas Medical Center, USA
Yong Peng, PhD, MD, West China Hospital, Sichuan University, China
Weihong Song, PhD, MD, The University of British Columbia, Canada

Editorial Board
Rami I. Aqeilan, PhD, Hebrew University-Hadassa Medical Center, Israel
Yossef Av-Gay, PhD, The University of British Columbia, Canada
Anupam Bishayee, PhD, Lake Erie College of Osteopathic Medicine, USA
Jijie Chai, PhD, Tsinghua University, China
Hongkui Deng, PhD, Peking University, China
Bisen Ding, PhD, West China Second Hospital, Sichuan University, China
Gideon Dreyfuss, PhD, University of Pennsylvania, USA
Arnold J. M. Driessen, PhD, University of Groningen, Netherlands
Muller Fabbri, PhD, MD, University of Hawaii Cancer Center, USA
Alemayehu Gorfe, PhD, The University of Texas McGovern Medical School at Houston, USA
Illana Gozes, PhD, Tel Aviv University, Israel
Roger G. Harrison, PhD, School of Chemical, Biological and Materials Engineering, University of Oklahoma, USA
Peter E. Huber, PhD, MD, German Cancer Research Center and University Hospital Center Heidelberg, Germany
Balveen Kaur, PhD, The University of Texas Health Science Center at Houston, USA
Ajaikumar B. Kunnumakkara, PhD, Indian Institute of Technology Guwahati, India
Tatiana G. Kutateladze, PhD, Department of Pharmacology, University of Colorado School of Medicine, USA
Dong-Xu Liu, PhD, Auckland University of Technology, New Zealand
Jun Lu, PhD, School of Medicine, Yale University, USA
James Naismith, PhD, Wellcome Trust Centre for Human Genomics, United Kingdom
Markus Noll, PhD, University of Zurich, Switzerland
Takahiro Ochiya, PhD, Department of Molecular and Cellular Medicine Tokyo Medical University, Japan
Guo-hong Peng, PhD, Max Planck Institute of Biophysics, Germany
Shazib Pervaiz, PhD, School of Medicine, National University of Singapore, Singapore
Nikolai Petrovsky, PhD, College of Medicine and Public Health, Flinders University, Australia
Dietmar Schmucker, PhD, KU Leuven, Belgium
Gary Stoner, PhD, Montana State University, USA
Yoshimasa Tanaka, PhD, Center for Medical Innovation, Nagasaki University, Japan
David A. Winkler, PhD, La Trobe University, Australia
Xiaowei Xu, PhD, MD, University of Pennsylvania, USA
Eitan Yefenof, PhD, Department of Immunology, Hebrew University, Israel
Jianhua Yu, PhD, City of Hope National Medical Center, USA